All In Biotech

Drug Trial Radar · NCT01600755

Autologous Cell Therapy for Treatment of Fecal Incontinence

A Prospective Nonrandomized Study of Autologous Muscle Derived Cell (AMDC) Transplantation for Treatment of Fecal Incontinence

Last checked: Nov 19, 2026Latest source record: Feb 16, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

53

Actual

Start

Mar 28, 2013

Primary completion

Oct 27, 2021

Study completion Oct 27, 2021

Sponsor

Lead sponsor
Cook MyoSiteIndustry
Sponsor type
Industry
First posted
May 17, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of this clinical study is to investigate the safety and feasibility of Autologous Muscle Derived Cells (AMDC, generic name iltamiocel, preparation of a patient's own cells) injection into the anal sphincter for treatment of patients with fecal incontinence.

Conditions

  • Fecal Incontinence

Interventions

  • IltamiocelBiological

    Single intrasphincteric injection of iltamiocel at a dose of 250 x 10\^6 cells

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Treatment-Related Adverse EventsTime frame: 12 months

Locations

2 sites in 2 countries. Site status is shown where the registry gives one.

  • St. Paul's Hospital

    Vancouver, British Columbia, Canada

  • Royal London Hospital

    London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.